Viruses 2011, 3(6), 677-713; doi:10.3390/v3060677

Gammaretroviral Vectors: Biology, Technology and Application

email, email, * email and * email
Received: 8 March 2011; in revised form: 3 May 2011 / Accepted: 9 May 2011 / Published: 3 June 2011
(This article belongs to the Special Issue Retroviral Vectors)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Retroviruses are evolutionary optimized gene carriers that have naturally adapted to their hosts to efficiently deliver their nucleic acids into the target cell chromatin, thereby overcoming natural cellular barriers. Here we will review—starting with a deeper look into retroviral biology—how Murine Leukemia Virus (MLV), a simple gammaretrovirus, can be converted into an efficient vehicle of genetic therapeutics. Furthermore, we will describe how more rational vector backbones can be designed and how these so-called self-inactivating vectors can be pseudotyped and produced. Finally, we will provide an overview on existing clinical trials and how biosafety can be improved.
Keywords: Murine Leukemia Virus; gammaretroviral; split packaging design; SIN vector
PDF Full-text Download PDF Full-Text [835 KB, uploaded 3 June 2011 15:08 CEST]

Export to BibTeX |

MDPI and ACS Style

Maetzig, T.; Galla, M.; Baum, C.; Schambach, A. Gammaretroviral Vectors: Biology, Technology and Application. Viruses 2011, 3, 677-713.

AMA Style

Maetzig T, Galla M, Baum C, Schambach A. Gammaretroviral Vectors: Biology, Technology and Application. Viruses. 2011; 3(6):677-713.

Chicago/Turabian Style

Maetzig, Tobias; Galla, Melanie; Baum, Christopher; Schambach, Axel. 2011. "Gammaretroviral Vectors: Biology, Technology and Application." Viruses 3, no. 6: 677-713.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert